Custom Antibody Market worth $860 million by 2028, growing at a CAGR of 9.4% in the upcoming years.
Various elements such as rising research activities and funding investments for antibody developments, and the quality concerns over catalog antibodies problems associated with them, are driving the market growth. However, the presence of alternatives to the antibodies is likely to hinder the growth of this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164328301
Browse in-depth TOC on "Custom Antibody Market”
166 – Tables
29 – Figures
189 – Pages
Key Market Players
The prominent players operating in the custom antibody market are Thermo Fisher Scientific Inc. (US), GenScript (China), Merck KGaA (Germany), Abcam (US), and Agilent Technologies, Inc. (US).
Thermo Fisher Scientific (US)
Thermo Fisher Scientific (US) is one of the leading player in the custom antibody market in 2022. The company’s leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of organic and inorganic growth strategies. The company has adopted different growth strategies, such as deals that include agreements, acquisitions, and expansions, to maintain its leading position in the custom antibody market. Thermo Fisher Scientific caters to the life sciences industry’s needs by introducing new products and related services in the market. For example, in October 2022, the company acquired The Binding Site Group (“The Binding Site”), a global leader in specialty diagnostics.
Merck KGaA (Germany)
Merck KGAA is one of the leading player in the life sciences market. Geographically, the company has a footprint in 65 countries across the globe and is further expanding its network. The company has adopted growth strategies such as expansions acquisitions and focusing on emerging markets to expand its presence in the custom antibody market. For instance, in December 2022, Merck KGaA collaborated with Kelun-Biotech to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer.
Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=164328301
Asia Pacific is likely to grow at double digit growth rate during the forecast period.
The Asia Pacific region is estimated to grow at the highest CAGR in the custom antibody market during the forecast period, this is mainly due to factors such the rising investment in research development, increased adoption of custom antibodies for various research and diagnostics purpose, emergence of new market players in custom antibody market.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=164328301
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/custom-antibody-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/custom-antibody.asp
Related Reports:
